{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:18:30Z","timestamp":1788290310702,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alcohol-related liver disease (ARLD) is a global health issue causing significant morbidity and mortality, due to lack of suitable therapeutic options. ARLD induces a spectrum of biochemical and cellular alterations, including chronic oxidative stress, mitochondrial dysfunction, and cell death, resulting in hepatic injury. Natural antioxidant compounds such as curcumin have generated interest in ARLD due to their ability to scavenge reactive oxygen species (ROS), however, therapy using these compounds is limited due to poor bioavailability and stability. Therefore, the aim of this study was to assess the antioxidant potential of free antioxidants and curcumin entrapped formulations against oxidative damage in an ARLD cell model. HepG2 (VL-17A) cells were treated with varying concentrations of alcohol (from 200 to 350\u00a0mM) and parameters of oxidative stress and mitochondrial function were assessed over 72\u00a0h. Data indicated 350\u00a0mM of ethanol led to a significant decrease in cell viability at 72\u00a0h, and a significant increase in ROS at 30\u00a0min. A substantial number of cells were in late apoptosis at 72\u00a0h, and a reduction in the mitochondrial membrane potential was also found. Pre-treatment with curcumin nanoformulations increased viability, as well as, reducing ROS at 2\u00a0h, 48\u00a0h and 72\u00a0h. In summary, antioxidants and entrapped nanoformulations of curcumin were able to ameliorate reduced cell viability and increased ROS caused by ethanol treatment. This demonstrates their potential at mitigating oxidative damage and warrants further investigation to evaluate their efficacy for ARLD therapy.<\/jats:p>","DOI":"10.1038\/s41598-025-91139-0","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:54:36Z","timestamp":1741182876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Oxidative stress in a cellular model of alcohol-related liver disease: protection using curcumin nanoformulations"],"prefix":"10.1038","volume":"15","author":[{"given":"Lucy","family":"Petagine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed G.","family":"Zariwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyanarayana","family":"Somavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie Ho Yi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evrim A.","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinood B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"91139_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0168-8278(12)61033-2","volume":"57","author":"P Mathurin","year":"2012","unstructured":"Mathurin, P. et al. EASL clinical practical guidelines: Management of alcoholic liver disease. J. Hepatol. 57, 399\u2013420 (2012).","journal-title":"J. Hepatol."},{"key":"91139_CR2","doi-asserted-by":"publisher","unstructured":"Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., Kamath, P. S. Global burden of liver disease: 2023 Update. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017 (2023).","DOI":"10.1016\/j.jhep.2023.03.017"},{"key":"91139_CR3","unstructured":"WHO. Global status report on alcohol and health 2018. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274603\/9789241565639-eng.pdf?ua=1."},{"key":"91139_CR4","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey, M. R., Mathurin, P. & Morgan, T. R. Alcoholic hepatitis. N. Engl. J. Med. 360, 2758 (2009).","journal-title":"N. Engl. J. Med."},{"key":"91139_CR5","doi-asserted-by":"publisher","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","volume":"20","author":"H Cichoz-Lach","year":"2014","unstructured":"Cichoz-Lach, H. & Michalak, A. Oxidative stress as a crucial factor in liver diseases. World J. Gastroenterol. 20, 8082\u20138091 (2014).","journal-title":"World J. Gastroenterol."},{"key":"91139_CR6","doi-asserted-by":"crossref","unstructured":"Tiniakos, D. G., Anstee, Q. M., Burt, A. D. Fatty liver disease. In Macsween\u2019s Pathology of the Liver 308\u2013371 (Elsevier, 2018).","DOI":"10.1016\/B978-0-7020-6697-9.00005-4"},{"key":"91139_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.molmed.2017.12.003","volume":"24","author":"HM Heymann","year":"2018","unstructured":"Heymann, H. M., Gardner, A. M. & Gross, E. R. Aldehyde-induced DNA and protein adducts as biomarker tools for alcohol use disorder. Trends Mol. Med. 24, 144\u2013155 (2018).","journal-title":"Trends Mol. Med."},{"key":"91139_CR8","doi-asserted-by":"publisher","unstructured":"Ayala, A., Mu\u00f1oz, M. F., Arg\u00fcelles, S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell Longev. 2014. https:\/\/doi.org\/10.1155\/2014\/360438 (2014).","DOI":"10.1155\/2014\/360438"},{"key":"91139_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4331\/wjbc.v12.i5.87","volume":"12","author":"L Petagine","year":"2021","unstructured":"Petagine, L., Zariwala, M. G. & Patel, V. B. Alcoholic liver disease: Current insights into cellular mechanisms. World J. Biol. Chem. 12, 87\u2013103 (2021).","journal-title":"World J. Biol. Chem."},{"key":"91139_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13193","volume":"55","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., Wu, R., Wang, X., Bao, X. & Lu, C. Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis. Cell Prolif. 55, e13193 (2022).","journal-title":"Cell Prolif."},{"key":"91139_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe, R. F. & Luedde, T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat. Rev. Gastroenterol. Hepatol. 15, 738\u2013752 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91139_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/495156","author":"H Kawaratani","year":"2013","unstructured":"Kawaratani, H. et al. The effect of inflammatory cytokines in alcoholic liver disease. Mediat. Inflamm. https:\/\/doi.org\/10.1155\/2013\/495156 (2013).","journal-title":"Mediat. Inflamm."},{"key":"91139_CR13","first-page":"237","volume":"37","author":"LE Nagy","year":"2015","unstructured":"Nagy, L. E. The role of innate immunity in alcoholic liver disease. Alcohol Res. 37, 237\u2013250 (2015).","journal-title":"Alcohol Res."},{"key":"91139_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1034\/j.1600-0676.2003.01804.x","volume":"23","author":"F Pessione","year":"2003","unstructured":"Pessione, F. et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int. 23, 45\u201353 (2003).","journal-title":"Liver Int."},{"key":"91139_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/gut.15.1.52","volume":"15","author":"PW Brunt","year":"1974","unstructured":"Brunt, P. W., Kew, M. C., Scheuer, P. J. & Sherlock, S. Studies in alcoholic liver disease in Britain: 1 Clinical and pathological patterns related to natural history. Gut. 15, 52\u201358 (1974).","journal-title":"Gut."},{"key":"91139_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.15288\/jsa.2001.62.211","volume":"62","author":"WR Miller","year":"2001","unstructured":"Miller, W. R., Walters, S. T. & Bennett, M. E. How effective is alcoholism treatment in the United States?. J. Stud. Alcohol. 62, 211\u2013220 (2001).","journal-title":"J. Stud. Alcohol."},{"key":"91139_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1756283X10378925","volume":"4","author":"TH Frazier","year":"2011","unstructured":"Frazier, T. H., Stocker, A. M., Kershner, N. A., Marsano, L. S. & McClain, C. J. Treatment of alcoholic liver disease. Therap. Adv. Gastroenterol. 4, 63\u201381 (2011).","journal-title":"Therap. Adv. Gastroenterol."},{"key":"91139_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192393","volume":"13","author":"E Hughes","year":"2018","unstructured":"Hughes, E., Hopkins, L. J. & Parker, R. Survival from alcoholic hepatitis has not improved over time. PLoS One. 13, e0192393 (2018).","journal-title":"PLoS One."},{"key":"91139_CR19","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1001\/jama.2023.4902","volume":"329","author":"A Louvet","year":"2023","unstructured":"Louvet, A. et al. Effect of prophylactic antibiotics on mortality in severe alcohol-related hepatitis: a randomized clinical trial. JAMA. 329, 1558\u20131566 (2023).","journal-title":"JAMA."},{"key":"91139_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/1745-6215-14-262","volume":"14","author":"E Forrest","year":"2013","unstructured":"Forrest, E. et al. Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials. 14, 262 (2013).","journal-title":"Trials."},{"key":"91139_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jhep.2017.11.017","volume":"68","author":"EH Forrest","year":"2018","unstructured":"Forrest, E. H. et al. Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis. J. Hepatol. 68, 511\u2013518 (2018).","journal-title":"J. Hepatol."},{"key":"91139_CR22","first-page":"364","volume":"3","author":"M Bartneck","year":"2014","unstructured":"Bartneck, M., Warzecha, K. T. & Tacke, F. Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg. Nutr. 3, 364\u201336476 (2014).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"91139_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15586\/jrenhep.v5i1.96","volume":"5","author":"L Petagine","year":"2021","unstructured":"Petagine, L., Everitt, H., Preedy, V., Sherwood, R. & Patel, V. Acute alcohol tissue damage: protective properties of betaine. J. Ren. Hepatic Disord. 5, 19\u201329 (2021).","journal-title":"J. Ren. Hepatic Disord."},{"key":"91139_CR24","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3389\/fphar.2021.694475","volume":"12","author":"J Yan","year":"2021","unstructured":"Yan, J., Nie, Y., Luo, M., Chen, Z. & He, B. Natural compounds: a potential treatment for alcoholic liver disease?. Front. Pharmacol. 12, 1695 (2021).","journal-title":"Front. Pharmacol."},{"key":"91139_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano10101945","volume":"10","author":"X Bai","year":"2020","unstructured":"Bai, X., Su, G. & Zhai, S. Recent advances in nanomedicine for the diagnosis and therapy of liver fibrosis. Nanomaterials. 10, 1\u201318 (2020).","journal-title":"Nanomaterials."},{"key":"91139_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3233\/JPD-191754","volume":"10","author":"L Mursaleen","year":"2020","unstructured":"Mursaleen, L., Somavarapu, S. & Zariwala, M. G. Deferoxamine and curcumin loaded nanocarriers protect against rotenone-induced neurotoxicity. J. Parkinsons Dis. 10, 99\u2013111 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"91139_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.taap.2006.05.003","volume":"216","author":"H Wu","year":"2006","unstructured":"Wu, H. et al. Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: Role of nonoxidative metabolism. Toxicol. Appl. Pharmacol. 216, 238\u2013247 (2006).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"91139_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/15376516.2016.1268229","volume":"27","author":"SM Kumar","year":"2017","unstructured":"Kumar, S. M. et al. The effects of changes in glutathione levels through exogenous agents on intracellular cysteine content and protein adduct formation in chronic alcohol-treated VL17A cells. Toxicol. Mech. Methods. 27, 128\u2013135 (2017).","journal-title":"Toxicol. Mech. Methods."},{"key":"91139_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biocel.2005.07.010","volume":"38","author":"TM Donohue","year":"2006","unstructured":"Donohue, T. M., Osna, N. A. & Clemens, D. L. Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity. Int. J. Biochem. Cell Biol. 38, 92\u2013101 (2006).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"91139_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.freeradbiomed.2009.05.014","volume":"47","author":"A Vald\u00e9s-Arzate","year":"2009","unstructured":"Vald\u00e9s-Arzate, A. et al. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism. Free Radic. Biol. Med. 47, 424\u2013430 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"91139_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4254\/wjh.v12.i3.84","volume":"12","author":"R Ghazali","year":"2020","unstructured":"Ghazali, R. et al. High omega arachidonic acid\/docosahexaenoic acid ratio induces mitochondrial dysfunction and altered lipid metabolism in human hepatoma cells. World J. Hepatol. 12, 84\u201398 (2020).","journal-title":"World J. Hepatol."},{"key":"91139_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","volume":"44","author":"Y Lu","year":"2008","unstructured":"Lu, Y. & Cederbaum, A. I. CYP2E1 and oxidative liver injury by alcohol. Free Radic. Biol. Med. 44, 723\u2013738 (2008).","journal-title":"Free Radic. Biol. Med."},{"key":"91139_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00204-009-0432-0","volume":"83","author":"AI Cederbaum","year":"2009","unstructured":"Cederbaum, A. I., Lu, Y. & Wu, D. Role of oxidative stress in alcohol-induced liver injury. Arch. Toxicol. 83, 519\u2013548 (2009).","journal-title":"Arch. Toxicol."},{"key":"91139_CR34","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.freeradbiomed.2012.09.024","volume":"53","author":"D Gyamfi","year":"2012","unstructured":"Gyamfi, D., Everitt, H. E., Tewfik, I., Clemens, D. L. & Patel, V. B. Hepatic mitochondrial dysfunction induced by fatty acids and ethanol. Free Radic. Biol. Med. 53, 2131\u20132145 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"91139_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051120","author":"W Kim","year":"2021","unstructured":"Kim, W., Jeong, H.-S., Kim, S.-C., Choi, C.-H. & Lee, K.-H. Chronic alcohol exposure of cells using controlled alcohol-releasing capillaries. Cells. https:\/\/doi.org\/10.3390\/cells10051120 (2021).","journal-title":"Cells."},{"key":"91139_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09540105.2015.1079597","volume":"27","author":"X She","year":"2016","unstructured":"She, X. et al. In vitro antioxidant and protective effects of corn peptides on ethanol-induced damage in HepG2 cells. Food Agric. Immunol. 27, 99\u2013110 (2016).","journal-title":"Food Agric. Immunol."},{"key":"91139_CR37","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/fsn3.2133","volume":"9","author":"Z-J Qian","year":"2021","unstructured":"Qian, Z.-J. et al. Intracellular ethanol-mediated oxidation and apoptosis in HepG2\/CYP2E1 cells impaired by two active peptides from seahorse (Hippocampus kuda bleeler) protein hydrolysates via the Nrf2\/HO-1 and akt pathways. Food Sci. Nutr. 9, 1584\u20131602 (2021).","journal-title":"Food Sci. Nutr."},{"key":"91139_CR38","first-page":"2306","volume":"41","author":"C-F Yang","year":"2018","unstructured":"Yang, C.-F. et al. NOX4\/ROS mediate ethanol-induced apoptosis via MAPK signal pathway in L-02 cells. Int. J. Mol. Med. 41, 2306\u20132316 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"91139_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5487\/TR.2018.34.1.023","volume":"34","author":"A-Y Na","year":"2018","unstructured":"Na, A.-Y. et al. Protective effect of isoliquiritigenin against ethanol-induced hepatic steatosis by regulating the SIRT1-AMPK pathway. Toxicol. Res. 34, 23\u201329 (2018).","journal-title":"Toxicol. Res."},{"key":"91139_CR40","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/cimb45020107","volume":"45","author":"SI Stoica","year":"2023","unstructured":"Stoica, S. I. et al. Molecular aspects of hypoxic stress effects in chronic ethanol exposure of neuronal cells. Curr. Issues Mol. Biol. 45, 1655\u20131680 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"91139_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1006\/abbi.1995.1400","volume":"321","author":"DL Clemens","year":"1995","unstructured":"Clemens, D. L., Halgard, C. M., Miles, R. R., Sorrell, M. F. & Tuma, D. J. Establishment of a recombinant hepatic cell line stably expressing alcohol dehydrogenase. Arch. Biochem. Biophys. 321, 311\u2013318 (1995).","journal-title":"Arch. Biochem. Biophys."},{"key":"91139_CR42","doi-asserted-by":"publisher","first-page":"077","DOI":"10.1159\/000083640","volume":"15","author":"P Baldini","year":"2005","unstructured":"Baldini, P. et al. Atrial natriuretic peptide effects on intracellular pH changes and ROS production in HEPG2 cells: role of p38 MAPK and phospholipase D. Cell Physiol. Biochem. 15, 077\u2013088 (2005).","journal-title":"Cell Physiol. Biochem."},{"key":"91139_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"key":"91139_CR44","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nprot.2007.77","volume":"2","author":"M Fenech","year":"2007","unstructured":"Fenech, M. Cytokinesis-block micronucleus cytome assay. Nat. Protoc. 2, 1084\u20131104 (2007).","journal-title":"Nat. Protoc."},{"key":"91139_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12010130","author":"L Mursaleen","year":"2023","unstructured":"Mursaleen, L., Chan, S. H. Y., Noble, B., Somavarapu, S. & Zariwala, M. G. Curcumin and N-acetylcysteine nanocarriers alone or combined with deferoxamine target the mitochondria and protect against neurotoxicity and oxidative stress in a co-culture model of Parkinson\u2019s disease. Antioxidants (Basel, Switzerland). https:\/\/doi.org\/10.3390\/antiox12010130 (2023).","journal-title":"Antioxidants (Basel, Switzerland)."},{"key":"91139_CR46","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00436-009-1535-5","volume":"105","author":"M Shahiduzzaman","year":"2009","unstructured":"Shahiduzzaman, M., Dyachenko, V., Khalafalla, R. E., Desouky, A. Y. & Daugschies, A. Effects of curcumin on Cryptosporidium parvum in vitro. Parasitol. Res. 105, 1155\u20131161 (2009).","journal-title":"Parasitol. Res."},{"key":"91139_CR47","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1167\/iovs.05-0580","volume":"47","author":"C Premanand","year":"2006","unstructured":"Premanand, C., Rema, M., Sameer, M. Z., Sujatha, M. & Balasubramanyam, M. Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Investig. Ophthalmol. Vis. Sci. 47, 2179\u20132184 (2006).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"91139_CR48","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.progpolymsci.2010.06.003","volume":"35","author":"ZL Tyrrell","year":"2010","unstructured":"Tyrrell, Z. L., Shen, Y. & Radosz, M. Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers. Prog. Polym. Sci. 35, 1128\u20131143 (2010).","journal-title":"Prog. Polym. Sci."},{"key":"91139_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104641","volume":"86","author":"S Somavarapu","year":"2023","unstructured":"Somavarapu, S. et al. Engineering artesunate-loaded micelles using spray drying for pulmonary drug delivery. J. Drug Deliv. Sci. Technol. 86, 104641 (2023).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"91139_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.colsurfb.2013.11.028","volume":"115","author":"MG Zariwala","year":"2014","unstructured":"Zariwala, M. G., Farnaud, S., Merchant, Z., Somavarapu, S. & Renshaw, D. Ascorbyl palmitate\/DSPE-PEG nanocarriers for oral iron delivery: Preparation, characterisation and in vitro evaluation. Colloids Surf. B Biointerfaces. 115, 86\u201392 (2014).","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"91139_CR51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijpharm.2009.12.007","volume":"387","author":"K Moribe","year":"2010","unstructured":"Moribe, K. et al. Ascorbyl dipalmitate\/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs. Int. J. Pharm. 387, 236\u2013243 (2010).","journal-title":"Int. J. Pharm."},{"key":"91139_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/antiox9070600","volume":"9","author":"L Mursaleen","year":"2020","unstructured":"Mursaleen, L., Noble, B., Chan, S. H. Y., Somavarapu, S. & Zariwala, M. G. N-Acetylcysteine nanocarriers protect against oxidative stress in a cellular model of Parkinson\u2019s disease. Antioxidants 9, 600 (2020).","journal-title":"Antioxidants"},{"key":"91139_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13010063","author":"E Schiano","year":"2024","unstructured":"Schiano, E. et al. Antioxidant and antidiabetic properties of a thinned-nectarine-based nanoformulation in a pancreatic \u03b2-cell line. Antioxidants. https:\/\/doi.org\/10.3390\/antiox13010063 (2024).","journal-title":"Antioxidants."},{"key":"91139_CR54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/02652048.2023.2175924","volume":"40","author":"SHY Chan","year":"2023","unstructured":"Chan, S. H. Y., Sheikh, K., Zariwala, M. G. & Somavarapu, S. Dry powder formulation of azithromycin for COVID-19 therapeutics. J. Microencapsul. 40, 217\u2013232 (2023).","journal-title":"J. Microencapsul."},{"key":"91139_CR55","doi-asserted-by":"crossref","unstructured":"Louvet A, hepatology PM-N reviews G&, 2015 undefined. Alcoholic liver disease: mechanisms of injury and targeted treatment. https:\/\/www.nature.com\/nrgastro\/journal\/v12\/n4\/abs\/nrgastro.2015.35.html (accessed 13 Nov 2019).","DOI":"10.1038\/nrgastro.2015.35"},{"key":"91139_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010150","author":"U Rastovic","year":"2024","unstructured":"Rastovic, U. et al. Human precision-cut liver slices: a potential platform to study alcohol-related liver disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25010150 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"91139_CR57","first-page":"3","volume":"44","author":"RZ Zhao","year":"2019","unstructured":"Zhao, R. Z., Jiang, S., Zhang, L. & Yu, Z. B. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 44, 3\u201315 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"91139_CR58","first-page":"147","volume":"38","author":"NA Osna","year":"2017","unstructured":"Osna, N. A., Donohue, T. M. & Kharbanda, K. K. Alcoholic liver disease: pathogenesis and current management. Alcohol Res. 38, 147\u2013161 (2017).","journal-title":"Alcohol Res."},{"key":"91139_CR59","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1053\/gast.2002.33613","volume":"122","author":"JB Hoek","year":"2002","unstructured":"Hoek, J. B., Cahill, A. & Pastorino, J. G. Alcohol and mitochondria: A dysfunctional relationship. Gastroenterology. 122, 2049\u20132063 (2002).","journal-title":"Gastroenterology."},{"key":"91139_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091749","author":"ID Cooper","year":"2023","unstructured":"Cooper, I. D., Kyriakidou, Y., Petagine, L., Edwards, K. & Elliott, B. T. Bio-hacking better health\u2014leveraging metabolic biochemistry to maximise healthspan. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12091749 (2023).","journal-title":"Antioxidants."},{"key":"91139_CR61","doi-asserted-by":"publisher","first-page":"e996","DOI":"10.1038\/cddis.2013.499","volume":"5","author":"K Wang","year":"2014","unstructured":"Wang, K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis. 5, e996\u2013e996 (2014).","journal-title":"Cell Death Dis."},{"key":"91139_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1042\/bj1880549","volume":"188","author":"J Vi\u00f1a","year":"1980","unstructured":"Vi\u00f1a, J., Estrela, J. M., Guerri, C. & Romero, F. J. Effect of ethanol on glutathione concentration in isolated hepatocytes. Biochem. J. 188, 549\u2013552 (1980).","journal-title":"Biochem. J."},{"key":"91139_CR63","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/alcalc\/agm166","volume":"43","author":"B Anthony","year":"2008","unstructured":"Anthony, B., Zhou, F. C., Ogawa, T., Goodlett, C. R. & Ruiz, J. Alcohol exposure alters cell cycle and apoptotic events during early neurulation. Alcohol Alcohol. 43, 261\u2013273 (2008).","journal-title":"Alcohol Alcohol."},{"key":"91139_CR64","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/mutage\/geq110","volume":"26","author":"B Benassi-Evans","year":"2011","unstructured":"Benassi-Evans, B. & Fenech, M. Chronic alcohol exposure induces genome damage measured using the cytokinesis-block micronucleus cytome assay and aneuploidy in human B lymphoblastoid cell lines. Mutagenesis. 26, 421\u2013429 (2011).","journal-title":"Mutagenesis."},{"key":"91139_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2020.108342","volume":"786","author":"M Fenech","year":"2020","unstructured":"Fenech, M. et al. Micronuclei as biomarkers of DNA damage, aneuploidy, inducers of chromosomal hypermutation and as sources of pro-inflammatory DNA in humans. Mutat. Res. Mutat. Res. 786, 108342 (2020).","journal-title":"Mutat. Res. Mutat. Res."},{"key":"91139_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115717","author":"J Hyun","year":"2021","unstructured":"Hyun, J., Han, J., Lee, C., Yoon, M. & Jung, Y. Pathophysiological aspects of alcohol metabolism in the liver. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22115717 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"91139_CR67","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10565-008-9115-5","volume":"25","author":"BE Farf\u00e1n Labonne","year":"2009","unstructured":"Farf\u00e1n Labonne, B. E. et al. Acetaldehyde-induced mitochondrial dysfunction sensitizes hepatocytes to oxidative damage. Cell Biol. Toxicol. 25, 599\u2013609 (2009).","journal-title":"Cell Biol. Toxicol."},{"key":"91139_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.15586\/jrenhep.v6i1.143","volume":"6","author":"L Petagine","year":"2022","unstructured":"Petagine, L., Everitt, H., Sherwood, R., Gyamfi, D. & Patel, V. B. Time-dependent alterations in liver oxidative stress due to ethanol and acetaldehyde. J. Ren. Hepatic Disord. 6, 56\u201366 (2022).","journal-title":"J. Ren. Hepatic Disord."},{"key":"91139_CR69","first-page":"882","volume":"25","author":"VB Patel","year":"2001","unstructured":"Patel, V. B. et al. Cardioprotective effect of propranolol from alcohol-induced heart muscle damage as assessed by plasma cardiac troponin-T. Alcohol Clin. Exp. Res. 25, 882\u2013889 (2001).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"91139_CR70","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/bph.13621","volume":"174","author":"AB Kunnumakkara","year":"2017","unstructured":"Kunnumakkara, A. B. et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br. J. Pharmacol. 174, 1325\u20131348 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"91139_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111214","volume":"136","author":"AM Pourbagher-Shahri","year":"2021","unstructured":"Pourbagher-Shahri, A. M., Farkhondeh, T., Ashrafizadeh, M., Talebi, M. & Samargahndian, S. Curcumin and cardiovascular diseases: Focus on cellular targets and cascades. Biomed. Pharmacother. 136, 111214 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"91139_CR72","doi-asserted-by":"crossref","unstructured":"Garodia, P., Hegde, M., Kunnumakkara, A. B., Aggarwal, B. B. Curcumin, inflammation, and neurological disorders: how are they linked? Integr. Med. Res. 100968 (2023)","DOI":"10.1016\/j.imr.2023.100968"},{"key":"91139_CR73","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/abr.abr_147_16","volume":"7","author":"AH Rahmani","year":"2018","unstructured":"Rahmani, A. H., Alsahli, M. A., Aly, S. M., Khan, M. A. & Aldebasi, Y. H. Role of curcumin in disease prevention and treatment. Adv. Biomed. Res. 7, 38 (2018).","journal-title":"Adv. Biomed. Res."},{"key":"91139_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124440","author":"M Jabczyk","year":"2021","unstructured":"Jabczyk, M., Nowak, J., Hudzik, B. & Zubelewicz-Szkodzi\u0144ska, B. Curcumin in metabolic health and disease. Nutrients. https:\/\/doi.org\/10.3390\/nu13124440 (2021).","journal-title":"Nutrients."},{"key":"91139_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12061212","author":"IF Machado","year":"2023","unstructured":"Machado, I. F., Miranda, R. G., Dorta, D. J., Rolo, A. P. & Palmeira, C. M. Targeting oxidative stress with polyphenols to fight liver diseases. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12061212 (2023).","journal-title":"Antioxidants."},{"key":"91139_CR76","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1038\/s41598-023-33023-3","volume":"13","author":"T Lukkunaprasit","year":"2023","unstructured":"Lukkunaprasit, T. et al. An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand. Sci. Rep. 13, 5824 (2023).","journal-title":"Sci. Rep."},{"key":"91139_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00365","author":"T Ge","year":"2020","unstructured":"Ge, T. et al. The role of the pentose phosphate pathway in diabetes and cancer. Front. Endocrinol. (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2020.00365 (2020).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"91139_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27020361","author":"H Amekyeh","year":"2022","unstructured":"Amekyeh, H., Alkhader, E., Sabra, R. & Billa, N. Prospects of curcumin nanoformulations in cancer management. Molecules. https:\/\/doi.org\/10.3390\/molecules27020361 (2022).","journal-title":"Molecules."},{"key":"91139_CR79","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s11051-010-9907-4","volume":"12","author":"M Sun","year":"2010","unstructured":"Sun, M. et al. Enhancement of transport of curcumin to brain in mice by poly(n-butylcyanoacrylate) nanoparticle. J. Nanoparticle Res. 12, 3111\u20133122 (2010).","journal-title":"J. Nanoparticle Res."},{"key":"91139_CR80","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.2174\/22123873MTEzBMDAb5","volume":"21","author":"B Helli","year":"2021","unstructured":"Helli, B. et al. Curcumin nanomicelle improves lipid profile, stress oxidative factors and inflammatory markers in patients undergoing coronary elective angioplasty; a randomized clinical trial. Endocr. Metab. Immune Disord. Drug Targets. 21, 2090\u20132098 (2021).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets."},{"key":"91139_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2023.103095","volume":"56","author":"M Hegde","year":"2023","unstructured":"Hegde, M. et al. Nanoformulations of curcumin: An alliance for effective cancer therapeutics. Food Biosci. 56, 103095 (2023).","journal-title":"Food Biosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91139-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:30:01Z","timestamp":1741185001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91139-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91139"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91139-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7752"}}